CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- 4 Shares withheld for taxes SVP & Chief Commercial Officer gave up 4,147 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 6,528 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,911 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Gift Executive Vice Chair gave 52,208 shares (gift)
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Medical Officer sold 1,458 shares at $20.00 ($29,160)
- 4 Open-market buy 10% owner bought 588,235 shares at $17.00 ($9,999,995)
- 4/A Planned sale Chief Corp Dev.&Strat. Officer sold 46,000 shares at an average $21.97 ($1,010,790)
- 4 Open-market sale Director sold 1,000,000 shares at an average $19.51 ($19,510,637)
- 4 Open-market sale Director sold 1,000,000 shares at an average $19.51 ($19,510,637)
- 4 Planned sale Chief Corp Dev.&Strat. Officer sold 45,000 shares at $22.00 ($990,000)
- 4 Planned sale Chief Medical Officer sold 30,625 shares at $22.00 ($673,750)
- 4 Planned sale Executive Vice Chair sold 20,000 shares at $20.76 ($415,200)
- 4 Open-market buy 10% owner bought 1,919,057 shares at an average $21.82 ($41,874,151)
Page 6 of 23 · 459 filings